Effects of topical carteolol on retinal arterial blood flow in primary open-angle glaucoma patients

Japanese Journal of Ophthalmology

Volumn 56, Issue 5, 2012, Pages 458-463

  Kawai, Motofumi ^a   Nagaoka, Taiji ^a   Takahashi, Atsushi ^a   Sato, Eiichi ^a   Yoshida, Akitoshi ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Carteolol; Glaucoma; Laser Doppler velocimetry; Retinal blood flow

Indexed keywords

CARTEOLOL;

ADULT; AGED; ARTERY DIAMETER; ARTICLE; BLOOD FLOW VELOCITY; CLINICAL ARTICLE; DRUG EFFECT; DRUG INSTILLATION; FEMALE; HUMAN; LASER DOPPLER FLOWMETRY; MALE; MORNING DOSAGE; OPEN ANGLE GLAUCOMA; PERFUSION PRESSURE; PRIORITY JOURNAL; RETINA ARTERY; RETINA BLOOD FLOW; TREATMENT DURATION;

ADMINISTRATION, TOPICAL; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD FLOW VELOCITY; CARTEOLOL; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; LASER-DOPPLER FLOWMETRY; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; REGIONAL BLOOD FLOW; RETINAL ARTERY;

EID: 84866731062     PISSN: 00215155     EISSN: 16132246     Source Type: Journal    
DOI: 10.1007/s10384-012-0156-1     Document Type: Article

References (27)

1. Yamazaki Y, Drance SM. The relationship between progression of visual field defects and retrobulbar circulation in patients with glaucoma. Am J Ophthalmol. 1997; 124:287-95.
2. Schumann J, Orgul S, Gugleta K, Dubler B, Flammer J. interocular difference in progression of glaucoma correlates with interocular differences in retrobulbar circulation. Am J Ophthalmol. 2000; 129:728-33.
3. Berisha F, Feke GT, Hirose T, McMeel JW, Pasquale LR. Retinal blood flow and nerve fiber layer measurements in early-stage open-angle glaucoma. Am J Ophthalmol. 2008; 146:466-72.
4. Yoshida A, Ogasawara H, Fujio N, Konno S, ishiko S, Kitaya N, et al. Comparison of short- and long-term effects of betaxolol and timolol on human retinal circulation. Eye (London). 1998; 12(Pt 5):848-53.
5. Tamaki Y, Araie M, Tomita K, Nagahara M, Tomidokoro A. Effect of topical beta-blockers on tissue blood flow in the human optic nerve head. Curr Eye Res. 1997; 16:1102-10.
6. Tamaki Y, Araie M, Tomita K, Tomidokoro A, Nagahara M. Effects of topical adrenergic agents on tissue circulation in rabbit and human optic nerve head evaluated with laser speckle tissue circulation analyzer. Surv Ophthalmol. 1997; 42(Suppl 1):S52-63.
7. Sugiyama T, Kojima S, ishida O, ikeda T. Changes in optic nerve head blood flow induced by the combined therapy of latanoprost and beta blockers. Acta Ophthalmol. 2009; 87:797-800.
8. Altan-Yaycioglu R, Turker G, Akdol S, Acunas G, izgi B. The effects of beta-blockers on ocular blood flow in patients with primary open angle glaucoma: a color Doppler imaging study. Eur J Ophthalmol. 2001; 11:37-46.
9. Montanari P, Marangoni P, Oldani A, Ratiglia R, Raiteri M, Berardinelli L. Color Doppler imaging study in patients with primary open-angle glaucoma treated with timolol 0.5% and carteolol 2%. Eur J Ophthalmol. 2001; 11:240-4.
10. Demailly P, Allaire C, Trinquand C. Ocular hypotensive efficacy and safety of once daily carteolol alginate. Br J Ophthalmol. 2001; 85:921-4.
11. Alm A. Ocular circulation. in: Kaufman PL, Alm A, editors. Adler's physiology of the eye. 10th ed. St. Louis: Mosby; 2003. p. 747-84.
12. Yoshida A, Feke GT, Mori F, Nagaoka T, Fujio N, Ogasawara H, et al. Reproducibility and clinical application of a newly developed stabilized retinal laser Doppler instrument. Am J Ophthalmol. 2003; 135:356-61.
13. Nagaoka T, Yoshida A. Noninvasive evaluation of wall shear stress on retinal microcirculation in humans. invest Ophthalmol Vis Sci. 2006; 47:1113-9.
14. Nagaoka T, ishii Y, Takeuchi T, Takahashi A, Sato E, Yoshida A. Relationship between the parameters of retinal circulation measured by laser Doppler velocimetry and a marker of early systemic atherosclerosis. invest Ophthalmol Vis Sci. 2005; 46:720-5.
15. Sato E, Feke GT, Menke MN, Wallace McMeel J. Retinal haemodynamics in patients with age-related macular degeneration. Eye (London). 2006; 20:697-702.
16. Sorensen SJ, Abel SR. Comparison of the ocular beta-blockers. Ann Pharmacother. 1996; 30:43-54.
17. Frishman WH, Kowalski M, Nagnur S, Warshafsky S, Sica D. Cardiovascular considerations in using topical, oral, and intravenous drugs for the treatment of glaucoma and ocular hypertension: focus on beta-adrenergic blockade. Heart Dis. 2001; 3:386-97.
18. Frishman WH, Covey S. Penbutolol and carteolol: two new betaadrenergic blockers with partial agonism. J Clin Pharmacol. 1990; 30:412-21.
19. Vanhoutte PM. Endothelial adrenoceptors. J Cardiovasc Pharmacol. 2001; 38:796-808.
20. Janczewski P, Boulanger C, iqbal A, Vanhoutte PM. Endothelium-dependent effects of carteolol. J Pharmacol Exp Ther. 1988; 247:590-5.
21. Nakamoto K, Yasuda N. Effect of carteolol hydrochloride on 24-hour variation of intraocular pressure in normal-tension glaucoma. Jpn J Ophthalmol. 2010; 54:140-3.
22. Bill A, Sperber GO. Control of retinal and choroidal blood flow. Eye (London). 1990; 4(Pt 2):319-25.
23. Su WW, Cheng ST, Hsu TS, Ho WJ. Abnormal flow-mediated vasodilation in normal-tension glaucoma using a noninvasive determination for peripheral endothelial dysfunction. invest Ophthalmol Vis Sci. 2006; 47:3390-4.
24. Su WW, Cheng ST, Ho WJ, Tsay PK, Wu SC, Chang SH. Glaucoma is associated with peripheral vascular endothelial dysfunction. Ophthalmology. 2008; 115:1173-8.
25. Cruickshank JM. The clinical importance of cardioselectivity and lipophilicity in beta blockers. Am Heart J. 1980; 100:160-78.
26. Ferrari-Dileo G. Beta 1 and beta 2 adrenergic binding sites in bovine retina and retinal blood vessels. invest Ophthalmol Vis Sci. 1988; 29:695-9.
27. Denis P, Elena PP. Retinal vascular beta-adrenergic receptors in man. Ophtalmologie. 1989; 3:62-4.